drugset / Trial / NCT02421029

Prolonged Gadolinium Retention After MRI Imaging

NCT02421029

NaSingle-groupOpen-labelDiagnostic

Summary

The researchers propose to investigate the prevalence of gadolinium in the urine of patients with a prior gadolinium-enhanced MRI before and after a edetate calcium disodium challenge. Moreover, will investigate if there is any correlation of gadolinium urine levels with levels of endogenous (e.g zinc) and xenobiotic metals.

Timeline

Start
2017-07
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Background Edetate Calcium Disodium Unknown 1 g Intravenous

Indications